GenSight Biologics S.A. (SIGHT.PA) Stock Price
€0.153 0.6%
to add to portfolio
AI Score
-
Alternative
5 -
Fundamental
2 -
Technical
3
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.
Sign up to get access to more historical data and insights on GenSight Biologics S.A., AI stock picks, stock alerts and much more.
SIGHT.PA AI Stock Analysis
AI stock analysis for SIGHT.PA is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like GenSight Biologics S.A. (SIGHT.PA) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
GenSight Biologics S.A. (SIGHT.PA) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of GenSight Biologics S.A. (SIGHT.PA), currently trading at €0.153, will... Sign up to access price prediction.
About SIGHT.PA
-
GenSight Biologics S.
-
Symbol
SIGHT.PA
-
Market
EURONEXT
-
Industry
Biotechnology
-
Market Cap
23.6M
Similar Stocks
 |
Valneva SE VLA.PA |
€3.8 2.2% |
5 |
 |
Financière de Tubize SA TUB.BR |
€169.2 0.5% |
8 |
 |
OSE Immunotherapeutics SA OSE.PA |
€5.91 1.9% |
6 |
 |
UCB SA UCB.BR |
€207.4 1.1% |
6 |
 |
Innate Pharma S.A. IPH.PA |
€1.72 2.6% |
5 |
SIGHT.PA Alternative Data
Web Traffic
GenSight Biologics S.A. receives an estimated 4241 monthly visitors to gensight-biologics.com, which is down by -8.4% over the last month.
-
Web Traffic
4241
-
Change from Previous Month
8.4%
-
3 Month Change
46.5%
-
YoY Change
46.5%
Twitter Followers
GenSight Biologics S.A. has 1,671 Twitter Followers on its main Twitter (also known as X) account.
-
Twitter Followers
1671
-
Daily Change
0.1%
-
1 Month Change
0%
-
3 Month Change
0.5%
-
YoY Change
0.5%
LinkedIn Followers
9,126 are following GenSight Biologics S.A. on LinkedIn, up by 0.7% over the last month.
-
LinkedIn Followers
9126
-
Daily Change
0.7%
-
1 Month Change
0.7%
-
3 Month Change
2.5%
-
YoY Change
2.5%
LinkedIn Employees
According to LinkedIn, GenSight Biologics S.A. has 33 employees, down by -2.9% over the last month.
-
LinkedIn Employees
33
-
Daily Change
2.9%
-
1 Month Change
2.9%
-
3 Month Change
2.9%
-
YoY Change
2.9%
News Mentions
GenSight Biologics S.A. was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
Reddit Mentions
GenSight Biologics S.A. has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
1 Month Change
0%
-
3 Month Change
0%
SIGHT.PA Financials
SIGHT.PA Key Metrics
-
Total Revenue
€897K
-
Net Income
-€8.2M
-
Earnings per Share
-€0.0749
-
Free cash flow
-€5.6M
-
EBITDA
-€7.4M
-
EBITDA Ratio
-8.26421
-
Total Assets
€10.8M
SIGHT.PA 2-year Revenue & Income
SIGHT.PA 2-year Free Cash Flow
SIGHT.PA Technicals
SIGHT.PA SMA
SIGHT.PA RSI
FAQ
What's the current price of GenSight Biologics S.A. (SIGHT.PA) Stock?
The price of an GenSight Biologics S.A. (SIGHT.PA) share is €0.153.
What's the market cap of GenSight Biologics S.A.?
The current market cap of GenSight Biologics S.A. is 23.6M.
What are some stocks similar to GenSight Biologics S.A. (SIGHT.PA) that investors often compare it to?
GenSight Biologics S.A. (SIGHT.PA) is often compared to similar stocks such as Valneva SE, Financière de Tubize SA, OSE Immunotherapeutics SA, UCB SA and Innate Pharma S.A..
What is the forecast for GenSight Biologics S.A.'s stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast GenSight Biologics S.A.'s stock price to be around €0.146 in 2026. Starting from the current price of €0.153, this represents a 4.6% change in price, indicating a bearish outlook for the stock.
How to buy GenSight Biologics S.A. (SIGHT.PA) Stock?
GenSight Biologics S.A. stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy GenSight Biologics S.A. shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.